Edition:
United States

Global Blood Therapeutics Inc (GBT.OQ)

GBT.OQ on NASDAQ Stock Exchange Global Select Market

33.01USD
20 Nov 2018
Change (% chg)

-- (--)
Prev Close
$33.01
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
276,340
52-wk High
$68.05
52-wk Low
$31.50

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 -0.827
Jun '18 0.00 -0.780
Mar '18 0.00 -0.870
FY 2017 Dec '17 0.00 -0.942
Sep '17 0.00 -0.660
Jun '17 0.00 -0.555
Mar '17 0.00 -0.596
FY 2016 Dec '16 0.00 -0.743
Sep '16 0.00 -0.577
Jun '16 0.00 -0.582
Mar '16 0.00 -0.564
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 13 0.00 0.00 0.00 0.00
Quarter Ending Mar-19 11 0.00 0.00 0.00 0.00
Year Ending Dec-18 13 0.00 0.00 0.00 6.82
Year Ending Dec-19 14 11.25 157.50 0.00 42.94
Earnings (per share)
Quarter Ending Dec-18 13 -0.88 -0.72 -1.02 -0.77
Quarter Ending Mar-19 12 -0.91 -0.74 -1.07 -0.75
Year Ending Dec-18 13 -3.37 -3.20 -3.50 -3.05
Year Ending Dec-19 14 -3.64 -1.12 -4.91 -3.63
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 79.36 29.34
P/E High - Last 5 Yrs. -- 265.87 45.80
P/E Low - Last 5 Yrs. -- 84.08 25.31
Beta -- 0.73 0.91
Price to Sales (TTM) -- 217.50 20.58
Price to Book (MRQ) 4.17 16.40 4.23
Price to Tangible Book (MRQ) 4.18 20.76 12.86
Price to Cash Flow (TTM) -- 48.38 21.19
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.42 1.65
Dividend Yield - 5 Year Avg -- 0.23 1.43
Dividend 5 Year Growth Rate -- 3.73 -8.12
Payout Ratio(TTM) -- 7.92 43.70

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 147.95 6.76
Sales (TTM) vs TTM 1 Yr. Ago -- 61.16 5.37
Sales - 5 Yr. Growth Rate -- 22.11 7.50
EPS (MRQ) vs Qtr. 1 Yr. Ago -25.34 79.14 28.07
EPS (TTM) vs TTM 1 Yr. Ago -33.87 -- --
EPS - 5 Yr. Growth Rate -- 20.47 7.61
Capital Spending - 5 Yr. Growth Rate -- 34.50 8.20

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 3.42 2.60
Current Ratio (MRQ) 14.56 6.52 3.62
LT Debt to Equity (MRQ) 0.00 18.23 9.93
Total Debt to Equity (MRQ) 0.00 24.16 13.84
Interest Coverage (TTM) -- -167.47 35.65

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 30.41 53.45
Gross Margin - 5 Yr. Avg. -- 47.56 52.35
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -157.37 16.18
Operating Margin (TTM) -- -1,765.04 -12.21
Operating Margin - 5 Yr. Avg. -- -170.51 11.72
Pre-Tax Margin (TTM) -- -1,697.73 -10.76
Pre-Tax Margin - 5 Yr. Avg. -- -173.18 12.03
Net Profit Margin (TTM) -- -1,693.59 -14.16
Net Profit Margin - 5 Yr. Avg. -- -173.54 8.28
Effective Tax Rate (TTM) -- 14.72 21.78
Effective Tax Rate - 5 Yr. Avg. -- 19.72 24.36

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 24,455,577 843,943,000
Net Income/Employee (TTM) -1,130,912 -3,607,776 98,316,608
Receivable Turnover (TTM) -- 8.35 5.42
Inventory Turnover (TTM) -- 2.90 4.00
Asset Turnover (TTM) 0.00 0.48 0.91

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -41.85 -0.72 10.84
Return on Assets - 5 Yr. Avg. -- 2.40 11.60
Return on Investment (TTM) -44.26 -0.30 13.58
Return on Investment - 5 Yr. Avg. -- 2.31 14.86
Return on Equity (TTM) -45.52 -2.98 15.11
Return on Equity - 5 Yr. Avg. -- -1.50 16.02
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -11.34 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Global Blood Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 6.57 10.01 99 91
13 Week -18.60 -15.08 99 93
26 Week -23.39 -23.69 99 91
52 Week -3.03 -7.92 99 98
YTD -4.02 -5.73 99 91
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 269
Total Shares Held: 54,275,565
3 Mo. Net Change: 1,282,511
# New Positions: 29
# Closed Positions: 46
# Increased Positions: 127
# Reduced Positions: 119
# Net Buyers: 8
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.